- Home
- Publications
- Publication Search
- Publication Details
Title
Blood-brain barrier, cytotoxic chemotherapies and glioblastoma
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 16, Issue 11, Pages 1285-1300
Publisher
Informa UK Limited
Online
2016-06-17
DOI
10.1080/14737175.2016.1202761
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ultrasound-induced opening of the blood-brain barrier to enhance temozolomide and irinotecan delivery: an experimental study in rabbits
- (2016) Kevin Beccaria et al. JOURNAL OF NEUROSURGERY
- Targeting Receptor-Mediated Transport for Delivery of Biologics Across the Blood-Brain Barrier
- (2015) Jason M. Lajoie et al. Annual Review of Pharmacology and Toxicology
- Enhanced brain distribution of carboplatin in a primate model after blood–brain barrier disruption using an implantable ultrasound device
- (2015) Lauriane Goldwirt et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Heterogeneous vascular permeability and alternative diffusion barrier in sensory circumventricular organs of adult mouse brain
- (2015) Shoko Morita et al. CELL AND TISSUE RESEARCH
- The Efficacy of the Wee1 Inhibitor MK-1775 Combined with Temozolomide Is Limited by Heterogeneous Distribution across the Blood-Brain Barrier in Glioblastoma
- (2015) J. L. Pokorny et al. CLINICAL CANCER RESEARCH
- Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature
- (2015) Megan O. Jacus et al. CLINICAL PHARMACOKINETICS
- Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma
- (2015) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cancer-treatment-induced neurotoxicity—focus on newer treatments
- (2015) Jacqueline B. Stone et al. Nature Reviews Clinical Oncology
- The effects of alternating electric fields in glioblastoma: current evidence on therapeutic mechanisms and clinical outcomes
- (2015) Azeem A. Rehman et al. Neurosurgical Focus
- Drug delivery strategies to enhance the permeability of the blood–brain barrier for treatment of glioma
- (2015) Fang Zhang et al. Drug Design Development and Therapy
- Neurosurgical Techniques for Disruption of the Blood–Brain Barrier for Glioblastoma Treatment
- (2015) Analiz Rodriguez et al. Pharmaceutics
- Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation
- (2014) J J M A Hendrikx et al. BRITISH JOURNAL OF CANCER
- Irinotecan and temozolomide brain distribution: a focus on ABCB1
- (2014) Lauriane Goldwirt et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastoma
- (2014) Neil U. Barua et al. DRUG DELIVERY
- Enhanced Doxorubicin Delivery to the Brain Administered Through Glutathione PEGylated Liposomal Doxorubicin (2B3-101) as Compared with Generic Caelyx,®/Doxil®—A Cerebral Open Flow Microperfusion Pilot Study
- (2014) Thomas Birngruber et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
- (2014) Walter Taal et al. LANCET ONCOLOGY
- The epidemiology of glioma in adults: a "state of the science" review
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)
- (2014) Pieter J. Gaillard et al. PLoS One
- Gliomas and the vascular fragility of the blood brain barrier
- (2014) Luiz Gustavo Dubois et al. Frontiers in Cellular Neuroscience
- SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug delivery
- (2013) Ching-Hsiang Fan et al. BIOMATERIALS
- Adjunctive use of verapamil in patients with refractory temporal lobe epilepsy: A pilot study
- (2013) Ali A. Asadi-Pooya et al. EPILEPSY & BEHAVIOR
- Improving the prediction of drug disposition in the brain
- (2013) Kiril Lanevskij et al. Expert Opinion on Drug Metabolism & Toxicology
- Net Clinical Benefit Analysis of Radiation Therapy Oncology Group 0525: A Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma
- (2013) Terri S. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
- (2013) Mark R. Gilbert et al. JOURNAL OF CLINICAL ONCOLOGY
- Tanycyte-like cells form a blood-cerebrospinal fluid barrier in the circumventricular organs of the mouse brain
- (2013) Fanny Langlet et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Transporters of the blood–brain and blood–CSF interfaces in development and in the adult
- (2013) Norman R. Saunders et al. MOLECULAR ASPECTS OF MEDICINE
- Focused Ultrasound-Induced Blood–Brain Barrier Opening to Enhance Temozolomide Delivery for Glioblastoma Treatment: A Preclinical Study
- (2013) Kuo-Chen Wei et al. PLoS One
- Devices for overcoming biological barriers: The use of physical forces to disrupt the barriers
- (2012) Samir Mitragotri ADVANCED DRUG DELIVERY REVIEWS
- The transport of non-surfactant based paclitaxel loaded magnetic nanoparticles across the blood brain barrier in a rat model
- (2012) Fahima Dilnawaz et al. BIOMATERIALS
- Temporary Disruption of the Blood-Brain Barrier by Use of Ultrasound and Microbubbles: Safety and Efficacy Evaluation in Rhesus Macaques
- (2012) N. McDannold et al. CANCER RESEARCH
- Phase II Study of Single-agent Bevacizumab in Japanese Patients with Recurrent Malignant Glioma
- (2012) M. Nagane et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
- (2012) Gregory Cairncross et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951
- (2012) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
- (2012) Annika Malmström et al. LANCET ONCOLOGY
- The disturbed blood–brain barrier in human glioblastoma
- (2012) Hartwig Wolburg et al. MOLECULAR ASPECTS OF MEDICINE
- Orally Bioavailable Tubulin Antagonists for Paclitaxel-Refractory Cancer
- (2012) Chien-Ming Li et al. PHARMACEUTICAL RESEARCH
- 7.0-T Magnetic Resonance Imaging Characterization of Acute Blood-Brain-Barrier Disruption Achieved with Intracranial Irreversible Electroporation
- (2012) Paulo A. Garcia et al. PLoS One
- Bevacizumab Attenuates VEGF-Induced Angiogenesis and Vascular Malformations in the Adult Mouse Brain
- (2012) Espen J. Walker et al. STROKE
- The circumventricular organs of the brain: conspicuity on clinical 3T MRI and a review of functional anatomy
- (2012) Avril Horsburgh et al. SURGICAL AND RADIOLOGIC ANATOMY
- ABC Transporters in the CNS – An Inventory
- (2011) A. M.S. Hartz et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Morphine facilitates doxorubicin penetration in the central nervous system: a new prospect for therapy of brain tumors
- (2011) Iacopo Sardi JOURNAL OF NEURO-ONCOLOGY
- Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors
- (2011) Yasuo Uchida et al. JOURNAL OF NEUROCHEMISTRY
- In Vitro Blood–Brain Barrier Models: Current and Perspective Technologies
- (2011) Pooja Naik et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Complete response induced by fotemustine given as single agent in a patient with primary central nervous system non-Hodgkin aggressive lymphoma relapsed after high-dose chemotherapy and autologous stem cell support
- (2011) Elsa Pennese et al. LEUKEMIA & LYMPHOMA
- Transcriptomic and Quantitative Proteomic Analysis of Transporters and Drug Metabolizing Enzymes in Freshly Isolated Human Brain Microvessels
- (2011) Ramzi Shawahna et al. MOLECULAR PHARMACEUTICS
- Regression of Recurrent Malignant Gliomas With Convection-Enhanced Delivery of Topotecan
- (2011) Jeffrey N. Bruce et al. NEUROSURGERY
- Electromagnetic fields and the blood–brain barrier
- (2010) Rianne Stam BRAIN RESEARCH REVIEWS
- Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide
- (2010) K A van Nifterik et al. BRITISH JOURNAL OF CANCER
- Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors
- (2010) Robert J. Morgan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy
- (2010) Shailendra Joshi et al. JOURNAL OF NEURO-ONCOLOGY
- Transnasal Delivery of Methotrexate to Brain Tumors in Rats: A New Strategy for Brain Tumor Chemotherapy
- (2010) Tomotaka Shingaki et al. MOLECULAR PHARMACEUTICS
- Membrane transporters in drug development
- (2010) NATURE REVIEWS DRUG DISCOVERY
- Transcranial Magnetic Resonance Imaging– Guided Focused Ultrasound Surgery of Brain Tumors
- (2010) Nathan McDannold et al. NEUROSURGERY
- OncoGel (ReGel/paclitaxel) — Clinical applications for a novel paclitaxel delivery system
- (2009) Nancy L. Elstad et al. ADVANCED DRUG DELIVERY REVIEWS
- Glioma-induced remodeling of the neurovascular unit
- (2009) Jisook Lee et al. BRAIN RESEARCH
- Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates
- (2009) Shana Jacobs et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Neuropharmacokinetics of Temozolomide in Patients with Resectable Brain Tumors: Potential Implications for the Current Approach to Chemoradiation
- (2009) J. Portnow et al. CLINICAL CANCER RESEARCH
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide
- (2009) Gregor Dresemann et al. JOURNAL OF NEURO-ONCOLOGY
- Delivery of temozolomide to the tumor bed via biodegradable gel matrices in a novel model of intracranial glioma with resection
- (2009) Umar Akbar et al. JOURNAL OF NEURO-ONCOLOGY
- Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human
- (2009) Mark S. Warren et al. PHARMACOLOGICAL RESEARCH
- Anatomy and Imaging of the Normal Meninges
- (2009) Neel Patel et al. SEMINARS IN ULTRASOUND CT AND MRI
- Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer
- (2008) J. Sigmond et al. ANNALS OF ONCOLOGY
- Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
- (2008) W Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
- A multi-institutional phase II study on second-line Fotemustine chemotherapy in recurrent glioblastoma
- (2008) Maria Grazia Fabrini et al. JOURNAL OF NEURO-ONCOLOGY
- Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma model
- (2008) Qingyu Zhou et al. NEURO-ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More